glutathione synthetase gene Frontiers γ-Glutamyl Cycle

doi: 10.1046/j.1365-2958.2001.02221.x

Puri et al., 2002

W tym przewodniku AHK-Cu traktowany jest wylacznie jako naukowe odniesienie porownawcze i nie jest samodzielnie oferowanym produktem

3.1.2 Other PEDs This group included other substances prohibited by WADA, such as non-approved substances (BPC-157) from Section S0, other anabolic agents (clenbuterol and SARMs) from Subsection S0, S1.2, peptide hormones and their releasing factors (AOD-9604, hGH 176-191, CJC-1295, ibutamoren, ipamorelin, and growth hormone-releasing peptide) from S2.2, growth factors and growth factor modulators (thymosin-4 and its derivative TB-500) from S2.3, beta-2 agonists (salbutamol and indacaterol) from S3, metabolic modulators (meldonium, GW1516, SR9009, SR9011, and insulins) from Section S4.4, and thyroid hormones

Typically 1-2 injections per week for an initial course of 5-10 sessions, followed by maintenance treatments every two weeks

The 2VP treated samples and standards should then be diluted in Assay Buffer and Sample Diluent according to the dilutions recommended for each sample type on pages 7 and 8 prior to using in the assay